Magnolol inhibits the resistance of ESBLs E. coli to fourth-generation cephalosporins in vitro and in vivo
Phytomedicine · 2026-03 · 152 · 157889
DOI: 10.1016/j.phymed.2026.157889 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026-03. Verfasst von Yin-Chao Tong und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Northwest A&F University, Yangling 712100, PR China. Hauptthemen laut MEDLINE: Biphenyl Compounds, Lignans, Escherichia coli, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Key Research and Development Program of Ningxia.
Abstract (Originalsprache)
BACKGROUND: Antimicrobial resistance (AMR) infection is attracting increasing attention, especially superbug infections. As a result, finding ways to reduce AMR is essential. For the time being, natural compound therapy for reducing AMR is an ideal choice. PURPOSE: This study aims to investigate the mechanism of magnolol reducing the AMR of E. coli in vitro and vivo. METHODS: The morphology and function of E. coli under magnolol treatment were assessed using a scanning electron microscope, qPCR, RNA-seq, and other methods. Moreover, the in vivo treatment effects of magnolol combined with antibiotics were evaluated by HE and IHC staining. RESULTS: In this study, we found that magnolol reduced the resistance of ESBL E. coli to the fourth-generation cephalosporin in vitro via two main mechanisms. Firstly, magnolol disrupts iron ion metabolism by increasing environmental iron uptake significantly (P ≤ 0.01), leading to a significant increase in intracellular ROS (P ≤ 0.01) and membrane damage. Secondly, magnolol significantly inhibits the relative mRNA expression of blaCTX-M-1 (P ≤ 0.01) and the CTX-M-1 enzyme activity in ESBL E. coli. Furthermore, we find that magnolol can inhibit ESBL E. coli in vivo by significantly reducing the TLR4-NFκB p65 pathway (P ≤ 0.01). CONCLUSION: In a word, our results indicate that magnolol is a natural antibacterial adjuvant with potent inhibitory activity against bacterial resistance and exerts this activity through multiple pathways, which has particular significance for the further study of the AMR mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Northwest A&F University, Yangling 712100, PR China.
- Jingnan Area of Deyang People's Hospital, Deyang People's Hospital, Deyang 618000, PR China.
- College of Veterinary Medicine, Northwest A&F University, Yangling 712100, PR China. Electronic address: ylzhangwm@nwafu.edu.cn.
- College of Veterinary Medicine, Northwest A&F University, Yangling 712100, PR China. Electronic address: ylqingsuzhu@nwafu.edu.cn.
Förderung
- Key Research and Development Program of Ningxia
Zitieren
APA
Tong, Y. C., Lin, H., Yang, Y., Zhou, Z. F., Zhang, Y. N., Wang, J., Ma, W. R., Wang, Y., Zhang, W. M., & Qing, S. Z. (2026). Magnolol inhibits the resistance of ESBLs E. coli to fourth-generation cephalosporins in vitro and in vivo. Phytomedicine, 152, 157889. https://doi.org/10.1016/j.phymed.2026.157889
Vancouver
Tong YC, Lin H, Yang Y, Zhou ZF, Zhang YN, Wang J, et al. Magnolol inhibits the resistance of ESBLs E. coli to fourth-generation cephalosporins in vitro and in vivo. Phytomedicine. 2026;152:157889. doi:10.1016/j.phymed.2026.157889
BibTeX
@article{Tong2026,
author = {Tong, Yin-Chao and Lin, Huan and Yang, Yang and Zhou, Zhi-Fu and Zhang, Yi-Ning and Wang, Juan and Ma, Wu-Ren and Wang, Yongsheng and Zhang, Wei-Min and Qing, Su-Zhu},
title = {Magnolol inhibits the resistance of ESBLs E. coli to fourth-generation cephalosporins in vitro and in vivo},
journal = {Phytomedicine},
year = {2026},
volume = {152},
pages = {157889},
doi = {10.1016/j.phymed.2026.157889}
}
EUVIMED